CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Jul 6, 2012 · 10-Q · 36 days after period end · 0001303681-12-000065
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Net Income | -$4.00K | -$104.83K |
| EPS Diluted | -$0.01 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended May 31, 2012 · filed Jul 6, 2012 · 36 d after period end
